Correlation Between Cannabics Pharmaceuticals and Heron Therapeuti

Can any of the company-specific risk be diversified away by investing in both Cannabics Pharmaceuticals and Heron Therapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabics Pharmaceuticals and Heron Therapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannabics Pharmaceuticals and Heron Therapeuti, you can compare the effects of market volatilities on Cannabics Pharmaceuticals and Heron Therapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabics Pharmaceuticals with a short position of Heron Therapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabics Pharmaceuticals and Heron Therapeuti.

Diversification Opportunities for Cannabics Pharmaceuticals and Heron Therapeuti

-0.03

Correlation Coefficient

Cannabics Pharmaceuticals  Heron Therapeuti

Good diversification

The 3 months correlation between Cannabics and Heron is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Cannabics Pharmaceuticals and Heron Therapeuti in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heron Therapeuti and Cannabics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabics Pharmaceuticals are associated (or correlated) with Heron Therapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heron Therapeuti has no effect on the direction of Cannabics Pharmaceuticals i.e., Cannabics Pharmaceuticals and Heron Therapeuti go up and down completely randomly.

Pair Corralation between Cannabics Pharmaceuticals and Heron Therapeuti

Given the investment horizon of 90 days Cannabics Pharmaceuticals is expected to generate 2.13 times more return on investment than Heron Therapeuti. However, Cannabics Pharmaceuticals is 2.13 times more volatile than Heron Therapeuti. It trades about 0.05 of its potential returns per unit of risk. Heron Therapeuti is currently generating about -0.02 per unit of risk. If you would invest  1.17  in Cannabics Pharmaceuticals on October 12, 2024 and sell it today you would lose (0.17) from holding Cannabics Pharmaceuticals or give up 14.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.47%
Values	Daily Returns

Cannabics Pharmaceuticals  vs.  Heron Therapeuti

Cannabics Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Heron Therapeuti

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Heron Therapeuti has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Heron Therapeuti is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cannabics Pharmaceuticals and Heron Therapeuti

The main advantage of trading using opposite Cannabics Pharmaceuticals and Heron Therapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabics Pharmaceuticals position performs unexpectedly, Heron Therapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heron Therapeuti will offset losses from the drop in Heron Therapeuti's long position.

The idea behind Cannabics Pharmaceuticals and Heron Therapeuti pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..